E-ISSN: 2147-2688
Vaccination Rates in Geriatric Outpatient Clinic in Gaziantep Dr. Ersin Arslan Training and Research Hospital
PDF
Cite
Share
Request
Original Article
VOLUME: 57 ISSUE: 1
P: 75-78
March 2019

Vaccination Rates in Geriatric Outpatient Clinic in Gaziantep Dr. Ersin Arslan Training and Research Hospital

Med Bull Haseki 2019;57(1):75-78
DOI: 10.4274/haseki.galenos.2019.4794
Birkan İlhan 1
Oğuz Kağan Bakkaloğlu 2
1. Gaziantep Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Geriatri Bölümü, Gaziantep, Türkiye
2. Gaziantep Dr. Ersin Arslan Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, Gaziantep, Türkiye
No information available.
No information available
Received Date: 23.10.2018
Accepted Date: 14.01.2019
Publish Date: 19.03.2019
PDF
Cite
Share
Request

ABSTRACT

Aim:

Vaccination against influenza, pneumococcal disease, herpes zoster and tetanus-diphtheria-acellular pertussis (Tdap) is recommended for older adults. Data on vaccination rates in older adults are limited for our country. We aimed to investigate the prevalence of vaccination in community-dwelling older adults.

Methods:

Patients >= 65 years admitted to Dr. Ersin Arslan Research and Training Hospital geriatric outpatient clinic between September 2017 and May 2018 in Gaziantep were included. Demographic data and number of medicines were recorded. Frailty was assessed by the FRAIL scale. The patients were asked about their vaccination status against pneumococcal disease (conjugate vaccine in any period of life, polysaccharide vaccine in the past five years), influenza virus (for current year) and Tdap (in the past 10 years).

Results:

A total of 268 patients with the mean age of 76.7±7.2 years were included. Two hundred and four (76.1%) were female and 64 (23.9%) were male. The median number of drugs was 4 (0-16). Twenty one (7.8%) were robust and the remaining subjects were frail or prefrail. The prevalence of influenza vaccination was 8.2% (n=22) and pneumococcal vaccination was 0.7% (n=2, polysaccharide vaccine). There were no patients with herpes zoster or Tdap vaccines.

Conclusion:

In our study, we observed quite lower vaccination prevalence in older adults. Reporting vaccination rates in older adults may help draw health professionals’ attention to this issue, thereby increase vaccination rates.

References

1Shaw AC, Bandaranayake T Immunology of aging. In:Halter JB, Ouslander JG, Studenski S, editors. Hazzard’s Geriatric Medicine and Gerontology. 7th ed. United States: McGraw-Hill Education, 2017. p.101-18,
2Lee SJ, Walter LC, Prevention and Screening. In: Halter JB, Ouslander JG, Studenski S, editors. Hazzard’s Geriatric Medicine and Gerontology. 7th ed. United States: McGraw-Hill Education, 2017. p. 334-35,
3Türkiye Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Uzmanlık Derneği (EKMUD) Erişkin Bağışıklama Rehberi; Yaşlılık döneminde aşılama. İstanbul: Gülmat Matbaacılık: 2016.
4İstatistiklerle Yaşlılar, 2017. TÜİK Haber Bülteni 2018:27595.: file:///C:/Users/Administrator/Downloads/%C4% B0statistiklerle_Ya%C5%9Fl%C4%B1lar_15.03.2018.pdf Erişim tarihi: 01/09/2018
5Ciblak MA; Grip Platformu. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine 2013;31:518-23.
6Yürüyen M, Ayan G, Demirdağ F, et al. Why is vaccination frequency low in elderly patients? J Clin Anal Med 2018;9:138-42.
7Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478-86.
8Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: Personalized approaches. Hum Vaccin Immunother 2017;13:213-5.
9Biberoglu K. Haydi Buyukler Aş ıya. Actual Med 2006;14:18-26.
10Demirdogen Cetinoglu E, Uzaslan E, Sayıner A, et al; TURCAP Study Group. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation. Hum Vaccin Immunother 2017;13:2072-7.
11Tanriover MD, Soyler C, Ascioglu S, Cankurtaran M, Unal S. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Eur J Intern Med 2014;25:528-32.
12Baldo V, Cocchio S, Gallo T, et al. Pneu-mococcal Conjugated Vaccine Reduces the High Mortality for Community- Acquired Pneumonia in the Elderly: an Italian Regional Experience. PLoS One 2016;11:e0166637.
13Jimenez-Garcia R, Jimenez I, Garrido PC, et al. Coverage and predictors of influenza vaccination among adults with diabetes in Spain. Diabetes Res Clin Pract 2008;79:510-7.
14Kroneman M, Paget WJ, van Essen GA. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination up-take. Euro Surveill 2003;8:130-8.
15Cimen P, Unlu M, Kirakli C, et al. Should Patients With COPD Be Vaccinated? Respir Care 2015;60:239-43.
16Li C, Gubbins PO, Chen GJ. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. J Hosp Med 2015;10:287-93.
17Mangen MJ, Rozenbaum MH, Huijts SM, et al. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. Eur Respir J 2015;46:1407-16.
18Oxman MN, Levin MJ, Johnson GR, et al; Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271-84.
19Luigi Ferrucci, Elisa Fabbri, Jeremy D. Walston Frailty. In:Halter JB, Ouslander JG, Studenski S, editors. Hazzard’s Geriatric Medicine and Gerontology. 7th ed. United States: McGraw-Hill Education, 2017. p.988-1000.
Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House